Transcript EU Drugs Action Plan 2005-2008 - Emcdda

Monitoring and reporting on the drug
phenomenon in Europe
EMCDDA mandate and activities
Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008
Outline of the presentation
• Mission of the EMCDDA
• Structure of the Centre
• EU Drugs Strategy and Action Plan
• Priorities and principals of the EMCDDA
work programmes
2
European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA)
• The central reference point for drug
information in the EU
• Established in 1993, based in Lisbon
• A decentralised European Union agency
• agencies are an answer to a desire for
geographical devolution and the need to
cope with new tasks of a technical and/or
scientific nature
3
Legal basis
• Regulation (EC) No 1920/2006 of the European
Parliament and of the Council
(12 December 2006) on the European
Monitoring Centre for Drugs and Drug Addiction
(recast)
• Council Decision 2005/387/JHA of 10 May
2005 on the information exchange, risk
assessment and control of new psychoactive
substances
4
EMCDDA – Mission
• To collect, analyse and disseminate factual,
objective, reliable and comparable information on
drugs and drug addiction and their consequences
• To provide an evidence based picture of the drug
phenomenom at European level
New mission statement (2007) broadens scope:
• collect, register, analyse information on emerging trends in
polydrug use, including combined use of licit and illicit
psychoactive substances
• provide information on best practice in Member States
and facilitate exchange of such practice between them
5
EMCDDA - Main tasks
• Collecting and analysing existing data
• Improving data-comparison methods
• Disseminating data
• Cooperating with European and international
bodies/organisations and with non-EU countries
• Informing Member States about new developments and changing trends
6
In-house structure
Director
Reitox and international cooperation
Scientific
Coordination
Epidemiology, crime and markets
Interventions, law and policies
Scientific partners and documentation
Communication
ICT
Administration
7
Decisional and operational structure
Management Board
Member States
European Commission (2)
European Parliament (2)
Observers
Scientific
Committee
Director
Staff
8
Executive
Committee
Reitox
network
The EU approach
• EU Drugs Strategy 2005-2012
• EU Drugs Action Plan 2005-2008
(EU Drugs Action Plan 2009-2012)
9
EU Drugs Strategy (2005-2012): structure
Demand
reduction
Supply
reduction
International cooperation
Research, information and evaluation
10
EU Drugs Action Plan 2005-2008: Content
Five areas of intervention
•
•
•
•
•
Coordination
Demand reduction
Supply reduction
International cooperation
Information, research,
evaluation
6 objectives, 9 actions
11 objectives, 18 actions
10 objectives, 24 actions
11 objectives, 21 actions
8 objectives, 14 actions
46 objectives, 86 actions
11
EMCDDA contribution to the EU Action Plan
• Participates in the definition of the assessment
tools/indicators for the implementation of Action
Plan
• Supports the EC for progress reports: drafting of
thematic papers, mainly in the areas of
coordination, drug demand reduction and
information/research/evaluation
• Contributes to the impact assessment in 2008
(the drug situation in the EU 2004-2008)
12
EMCDDA work programmes
• 3-year work programme 2007-2009
• Annual work programme 2008
In the context of
• EMCDDA regulation (recast)
• EU drugs strategy and action plan
• Council decision on psychoactive substances
13
3-year work programme: guiding principles and priorities
Consolidate
monitoring and
reporting activities
Enhance data
analysis
Scientific
Excellence
Commitment
to partnership
Good
governance
and efficiency
14
Communicate
more effectively
www.emcdda.europa.eu
15